SSelectStock
Sign in

PGHLProcter & Gamble Health Limited

Pharma · Drug Manufacturers - Specialty & Generic · NSE · as of 2026-07-19 (delayed ~30 min in market hours)

6,799.50
0.80%
83Excellent

Price & Volume

Loading chart…

Key Ratios

Market Cap (₹ cr)11,484.30
P/E35.11
P/B21.89
PEG0.64
ROE %61.59
ROCE %81.10
Debt / Equity0.02
EPS197.08
Revenue Growth %19.10
Profit Growth %54.60
Dividend Yield %2.99
Promoter Holding %52.20
FII Holding %16.45
DII Holding %
Beta0.23

“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.

Active Pattern Signals

Bollinger SqueezeLONG41%6,918.506,392.777,969.952.00
BUYConfidence 91%
  • Revenue growth: 19.1% YoY
  • Profit growth: 54.6% YoY
  • ROE: 61.6%
  • RSI: 69
  • MACD: bullish
  • Price vs EMA21: above
  • Bollinger Squeeze signal (confidence 41%)

Bull case

  • Revenue growth: 19.1% YoY
  • Profit growth: 54.6% YoY
  • ROE: 61.6%
  • RSI: 69

Bear case

  • Volume: 0.3x 20-day average

Key risks

  • Volume: 0.3x 20-day average

Algorithmic analysis for research only — not SEBI-registered investment advice.

Trade Plan

Entry (CMP)
₹6,799.50
Stop Loss
₹6,380.64
risk 6.2%
Target 1 (1.5R)
₹7,427.78
+9.2%
Target 2 (3R)
₹8,056.07
+18.5%
Support (20d)
₹6,180.00
Resistance (52w)
₹6,975.00
Risk : Reward
1 : 1.5 → 1 : 3
risking ₹418.86/share
ATR (volatility)
₹167.54
avg daily range

Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹167.54). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.

Score Breakdown

Fundamental
93
Technical
77
Momentum
86
Risk (safety)
73

Peers — Pharma

AJANTPHARM 0.97%
81
GRANULES 2.49%
81
HESTERBIO 0.42%
80
CORONA 0.13%
80
SUNPHARMA 0.90%
79
LUPIN 1.58%
78

About

Procter & Gamble Health Limited manufactures and markets pharmaceuticals and chemical products in India and internationally. The company offers over-the-counter products, vitamins, minerals, and supplements. It offers its products under the Polybion, Cosome, Evion, Neurobion, Nasivion, Livogen, and Seven Seas brands. The company was formerly known as Merck Limited and changed its name to Procter & Gamble Health Limited in May 2019. Procter & Gamble Health Limited was incorporated in 1967 and is headquartered in Mumbai, India. Procter & Gamble Health Limited is a subsidiary of Procter & Gamble Overseas India B.V.